USPTO 2015–2025 USPTO PatentsView US Corporation

ZYVEX LABS, LLC

USPTO PatentsView assignee record — 8 granted patents across 13 technology areas, active 2016–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).

8
Total patents granted
13
CPC technology areas
25.4
Avg claims per patent
-40%
5-year filing velocity

Portfolio overview

ZYVEX LABS, LLC has been granted 8 US utility patents between 2016 and 2022, placing ZYVEX LABS, LLC at rank #33,978 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 25.4 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a US Corporation, ZYVEX LABS, LLC is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 37.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 5 in the 2015–2019 window — a -40% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. ZYVEX LABS, LLC's 25.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark ZYVEX LABS, LLC against peers pursuing similar technology classes.

How does ZYVEX compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows ZYVEX holds 8 patents — placing it at rank #33,978 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2016–2022

0.511.522.5 201620182019202020212022 1
USPTO utility patent grants by year · 2016–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
ZYVEX LABS, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 2 25.0%
2018 2 25.0%
2019 1 12.5%
2020 1 12.5%
2021 1 12.5%
2022 1 12.5%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Velocity Declining

Where it ranks

Overall rank by patents

#33,978

Across all tracked assignees

Innovation Score

37.6 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does ZYVEX LABS, LLC hold?
ZYVEX LABS, LLC holds 8 US granted patents filed between 2016 and 2022, spanning 13 technology areas.
What is ZYVEX LABS, LLC's Innovation Score?
ZYVEX LABS, LLC has an Innovation Score of 37.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does ZYVEX LABS, LLC focus on?
ZYVEX LABS, LLC's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 4 patents. The company has filed patents in 13 CPC subclasses total.
Is ZYVEX LABS, LLC's patent filing rate increasing or decreasing?
ZYVEX LABS, LLC's recent filing velocity is -40% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for ZYVEX LABS, LLC's patents?
ZYVEX LABS, LLC's patents average 25.4 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the ZYVEX LABS, LLC patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope